Minoxipel (Minoxidil)

Minoxidil, the active ingredient in Minoxipel, is a potassium channel opener presented as a topical solution for scalp use. It is used to stimulate hair growth in individuals with pattern hair loss and other non‑scarring alopecia conditions.

GNH USA supplies Minoxipel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minoxipel is a topical agent indicated for hair‑loss conditions that affect the scalp.

- Androgenetic alopecia (male pattern hair loss): stimulates regrowth of thinning scalp hair. - Female pattern hair loss: improves hair density in women with androgenetic alopecia. - Other non‑scarring hair loss (e.g., telogen effluvium): may aid in restoring lost hair.

Common Side Effects: - Scalp irritation: itching, burning, or stinging at the application site. - Dryness or flaking of the scalp skin. - Redness or mild erythema. - Unwanted facial or body hair growth. - Temporary increased shedding of existing hairs.

Serious or Rare Side Effects: - Severe allergic reaction: contact dermatitis, swelling, or hives. - Chest pain or palpitations. - Dizziness or faintness. - Rapid heartbeat (tachycardia). - Unexplained weight gain or swelling of extremities.

Before using Minoxipel, consider the following precautions: - Pregnancy: safety not established; avoid unless benefits outweigh risks. - Breastfeeding: unknown safety; consult a healthcare professional. - Scalp condition: do not apply to irritated, infected, or inflamed skin. - Application: use only as directed; avoid excessive amounts. - Discontinue: stop use and seek medical advice if severe irritation or allergic reaction occurs. - Store at below 25°C: keep in the original container, protect from moisture and heat.

Minoxipel may interact with other substances; consider these interaction categories.

Major Interactions (Avoid): - Oral antihypertensive agents: additive blood‑pressure‑lowering effect. - Other topical vasodilators: increased risk of scalp irritation.

Moderate Interactions (Monitor Closely): - Topical hair‑care products containing irritants (e.g., certain shampoos, dyes). - Systemic vasodilators or nitrates: monitor for hypotension. - Beta‑blockers: possible alteration of cardiovascular response. - Hair‑growth supplements: assess for overlapping mechanisms.